ACEBUTOLOL HYDROCHLORIDE

ACEBUTOLOL HYDROCHLORIDE was reported 1283 times

ACEBUTOLOL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SEDATION COMPLICATION 499 0.1954
1 MULTIPLE DRUG THERAPY 107 0.1419
2 CREATININE RENAL CLEARANCE DECREASED 494 0.1233
3 DYSLOGIA 1 0.0833
4 CREATININE RENAL CLEARANCE INCREASED 56 0.0749
5 DRUG SPECIFIC ANTIBODY 63 0.0460
6 BLOOD CALCIUM DECREASED 494 0.0439
7 ORTHOSTATIC HYPOTENSION 582 0.0334
8 NIH STROKE SCALE ABNORMAL 1 0.0323
9 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 16 0.0306
10 SEDATION 547 0.0209
11 EROSIVE PUSTULAR DERMATOSIS 1 0.0200
12 CARDIOVASCULAR DECONDITIONING 1 0.0172
13 ENDOMETRIOSIS 78 0.0163
14 MIXED DEMENTIA 1 0.0156
15 CREATININE RENAL CLEARANCE 1 0.0152
16 RENAL FUNCTION TEST ABNORMAL 68 0.0146
17 COGNITIVE DISORDER 646 0.0138
18 BRONCHIAL HYPERREACTIVITY 16 0.0133
19 DEPRESSED LEVEL OF CONSCIOUSNESS 510 0.0129
20 CARDIAC PACEMAKER MALFUNCTION 1 0.0125
21 MYOFASCITIS 1 0.0120
22 SYNOVIAL FLUID ANALYSIS 1 0.0115
23 LYMPHOCELE 7 0.0105
24 PULMONARY FUNCTION TEST ABNORMAL 16 0.0103
25 GRAM STAIN POSITIVE 2 0.0097
26 VAGINAL CANDIDIASIS 1 0.0093
27 BLOOD PRESSURE INADEQUATELY CONTROLLED 54 0.0090
28 PLATELET AGGREGATION INCREASED 1 0.0083
29 EXERCISE TOLERANCE DECREASED 46 0.0080
30 URETERIC STENOSIS 6 0.0075
31 MOBILITY DECREASED 533 0.0074
32 BLOOD GROWTH HORMONE INCREASED 4 0.0072
33 BALANCE DISORDER 577 0.0067
34 HEPATOJUGULAR REFLUX 1 0.0060
35 STASIS DERMATITIS 4 0.0058
36 ISCHAEMIC CARDIOMYOPATHY 16 0.0052
37 SKIN SENSITISATION 5 0.0048
38 LINEAR IGA DISEASE 8 0.0048
39 BULLOUS HAEMORRHAGIC DERMATOSIS 1 0.0048
40 GRIP STRENGTH 1 0.0044
41 VASCULAR PURPURA 6 0.0043
42 HYPOCOAGULABLE STATE 4 0.0041
43 MYOGLOBIN URINE PRESENT 1 0.0041
44 WRONG PATIENT 2 0.0040
45 DIABETES MELLITUS INADEQUATE CONTROL 62 0.0035
46 CREUTZFELDT-JAKOB DISEASE 1 0.0035
47 SINOATRIAL BLOCK 2 0.0034
48 BREATH SOUNDS ABNORMAL 16 0.0032
49 COAGULATION FACTOR V LEVEL DECREASED 1 0.0031
50 DRUG SPECIFIC ANTIBODY PRESENT 19 0.0029
51 TOXICITY TO VARIOUS AGENTS 483 0.0029
52 HYPOTENSION 573 0.0029
53 BLADDER DISORDER 28 0.0028
54 INSULIN-LIKE GROWTH FACTOR INCREASED 4 0.0028
55 HYPOTHALAMO-PITUITARY DISORDER 4 0.0027
56 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 46 0.0027
57 CONSTIPATION 574 0.0026
58 PNEUMONIA MYCOPLASMAL 2 0.0025
59 DELUSIONAL DISORDER, PERSECUTORY TYPE 1 0.0024
60 SINUS RHYTHM 1 0.0023
61 CONGESTIVE HEPATOPATHY 1 0.0022
62 MUCOSAL EROSION 2 0.0022
63 PROTHROMBIN TIME SHORTENED 3 0.0021
64 IMMUNE-MEDIATED NEPHRITIS 1 0.0021
65 SUDDEN INFANT DEATH SYNDROME 1 0.0020
66 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0020
67 LABYRINTHITIS 5 0.0020
68 FALL 625 0.0019
69 OESOPHAGEAL FOOD IMPACTION 1 0.0018
70 MYOPATHY TOXIC 1 0.0016
71 BLOOD CORTISOL DECREASED 1 0.0016
72 OESOPHAGEAL ACHALASIA 1 0.0016
73 CEREBRAL HAEMATOMA 5 0.0015
74 DERMATITIS PSORIASIFORM 3 0.0015
75 PLEURAL THICKENING 1 0.0015
76 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
77 PANCREATIC CARCINOMA METASTATIC 4 0.0014
78 CRYOGLOBULINAEMIA 1 0.0014
79 TRANSIENT GLOBAL AMNESIA 1 0.0014
80 BODY TEMPERATURE DECREASED 13 0.0013
81 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
82 ELECTROCARDIOGRAM PR PROLONGATION 1 0.0013
83 DEMENTIA 36 0.0013
84 EOSINOPHILIA 22 0.0013
85 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 1 0.0012
86 ANAEMIA HAEMOLYTIC AUTOIMMUNE 1 0.0012
87 AXONAL NEUROPATHY 1 0.0011
88 HYPERLEUKOCYTOSIS 1 0.0011
89 CARDIOMYOPATHY 16 0.0011
90 SKIN TIGHTNESS 5 0.0011
91 HEPATIC NECROSIS 4 0.0011
92 ARTHRITIS 83 0.0011
93 HYPOGLYCAEMIC COMA 3 0.0010
94 CHRONIC KIDNEY DISEASE 77 0.0010
95 CELL DEATH 2 0.0010
96 DRUG INTOLERANCE 97 0.0010
97 TRIGEMINAL NEURALGIA 4 0.0010
98 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
99 OPTIC NEUROPATHY 2 0.0009
100 BLADDER DILATATION 1 0.0009
101 FACIAL SPASM 1 0.0009
102 DEPRESSED MOOD 46 0.0009
103 HYPOCHLORAEMIA 1 0.0009
104 MORBID THOUGHTS 1 0.0009
105 GLOMERULONEPHRITIS MEMBRANOUS 1 0.0009
106 DEPRESSIVE SYMPTOM 3 0.0009
107 BILE DUCT CANCER 1 0.0008
108 ASTHMA 95 0.0008
109 MEDICATION ERROR 46 0.0008
110 MIGRAINE 78 0.0008
111 PAIN 499 0.0008
112 HYDRONEPHROSIS 6 0.0008
113 PERIPHERAL SENSORIMOTOR NEUROPATHY 1 0.0008
114 SUBCUTANEOUS HAEMATOMA 1 0.0008
115 AMNESIA 48 0.0007
116 CALCULUS BLADDER 1 0.0007
117 TREATMENT NONCOMPLIANCE 39 0.0007
118 DRUG ABUSE 59 0.0007
119 HYPERTENSION 150 0.0007
120 SEBORRHOEIC KERATOSIS 1 0.0007
121 BLOOD CALCIUM INCREASED 6 0.0007
122 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
123 APRAXIA 1 0.0007
124 BLOOD CULTURE POSITIVE 2 0.0007
125 CONTUSION 63 0.0007
126 HAEMORRHAGIC STROKE 5 0.0006
127 RESPIRATORY RATE DECREASED 2 0.0006
128 DRUG INTERACTION 100 0.0006
129 MULTIPLE DRUG OVERDOSE INTENTIONAL 2 0.0006
130 RASH VESICULAR 3 0.0006
131 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
132 PSORIASIS 79 0.0006
133 RESUSCITATION 1 0.0006
134 CYTOLYTIC HEPATITIS 2 0.0006
135 VEIN RUPTURE 1 0.0006
136 POTENTIATING DRUG INTERACTION 2 0.0006
137 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1 0.0006
138 SEIZURE LIKE PHENOMENA 1 0.0006
139 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
140 ECCHYMOSIS 4 0.0006
141 POLYMYOSITIS 1 0.0006
142 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
143 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0006
144 OPHTHALMIC HERPES ZOSTER 1 0.0006
145 OESOPHAGEAL SPASM 1 0.0005
146 FOOT DEFORMITY 6 0.0005
147 INTERVERTEBRAL DISCITIS 1 0.0005
148 SPUTUM DISCOLOURED 5 0.0005
149 FAECES HARD 2 0.0005
150 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
151 CEREBRAL ATROPHY 2 0.0005
152 CANDIDIASIS 2 0.0005
153 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2 0.0005
154 HYPOSPADIAS 1 0.0005
155 OEDEMA PERIPHERAL 58 0.0005
156 HEPATITIS ACUTE 3 0.0005
157 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
158 HEPATOCELLULAR DAMAGE 1 0.0004
159 GASTRIC POLYPS 1 0.0004
160 NEPHROTIC SYNDROME 3 0.0004
161 PANCREATITIS NECROTISING 1 0.0004
162 APHTHOUS STOMATITIS 1 0.0004
163 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
164 HYPERTRANSAMINASAEMIA 3 0.0004
165 HYPERKALAEMIA 15 0.0004
166 URINE FLOW DECREASED 1 0.0004
167 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
168 STARING 1 0.0004
169 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
170 OSTEITIS 1 0.0004
171 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
172 PARKINSON'S DISEASE 1 0.0004
173 PHLEBITIS 2 0.0004
174 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
175 HYPOALBUMINAEMIA 3 0.0004
176 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
177 BRADYCARDIA 20 0.0004
178 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
179 ENDOTRACHEAL INTUBATION 1 0.0004
180 DEPRESSION 81 0.0004
181 PSYCHOMOTOR RETARDATION 1 0.0004
182 PERIPHERAL SWELLING 54 0.0004
183 FIBULA FRACTURE 1 0.0003
184 COMA SCALE ABNORMAL 1 0.0003
185 EYELID OEDEMA 4 0.0003
186 THERAPEUTIC REACTION TIME DECREASED 1 0.0003
187 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
188 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
189 STRABISMUS 1 0.0003
190 BLOOD IRON DECREASED 4 0.0003
191 HEPATITIS FULMINANT 1 0.0003
192 CREPITATIONS 1 0.0003
193 MIXED LIVER INJURY 1 0.0003
194 CEREBROVASCULAR DISORDER 1 0.0003
195 EYE INJURY 1 0.0003
196 DYSAESTHESIA 1 0.0003
197 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
198 AGRANULOCYTOSIS 6 0.0003
199 PHARYNGITIS 4 0.0003
200 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
201 LEUKAEMIA 3 0.0003
202 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
203 ORTHOPNOEA 1 0.0003
204 HEPATIC CYTOLYSIS 4 0.0003
205 SCIATICA 5 0.0003
206 CHOLESTASIS 6 0.0003
207 STUPOR 1 0.0003
208 SKIN EROSION 1 0.0003
209 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
210 ANGINA UNSTABLE 2 0.0003
211 INJECTION SITE INFECTION 1 0.0003
212 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
213 OVERDOSE 65 0.0003
214 PROSTATE CANCER METASTATIC 1 0.0003
215 PRODUCT USE IN UNAPPROVED INDICATION 73 0.0003
216 ABDOMINAL DISCOMFORT 49 0.0003
217 REGURGITATION 1 0.0003
218 LEFT VENTRICULAR FAILURE 1 0.0003
219 PRIAPISM 1 0.0003
220 VENTRICULAR EXTRASYSTOLES 3 0.0003
221 DUODENAL ULCER 2 0.0003
222 FIBRIN D DIMER INCREASED 1 0.0003
223 CONJUNCTIVAL HYPERAEMIA 1 0.0003
224 GOUT 5 0.0003
225 VENTRICULAR ARRHYTHMIA 1 0.0003
226 PEMPHIGOID 2 0.0003
227 MYOCARDIAL ISCHAEMIA 3 0.0003
228 FACE INJURY 1 0.0003
229 SLEEP APNOEA SYNDROME 5 0.0003
230 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
231 APNOEA 2 0.0003
232 RECURRENT CANCER 1 0.0002
233 ARTHRITIS BACTERIAL 1 0.0002
234 BRONCHITIS 18 0.0002
235 THYROID FUNCTION TEST ABNORMAL 1 0.0002
236 HEMIPLEGIA 2 0.0002
237 FACE OEDEMA 4 0.0002
238 HAEMATEMESIS 6 0.0002
239 LIP OEDEMA 1 0.0002
240 MUSCLE FATIGUE 1 0.0002
241 HYPONATRAEMIA 13 0.0002
242 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
243 DYSPHEMIA 1 0.0002
244 IRON DEFICIENCY 1 0.0002
245 ANAL INCONTINENCE 2 0.0002
246 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
247 LEUKOPENIA 11 0.0002
248 IRON DEFICIENCY ANAEMIA 2 0.0002
249 LACTIC ACIDOSIS 7 0.0002
250 ROSACEA 1 0.0002
251 TIBIA FRACTURE 1 0.0002
252 HEPATOCELLULAR INJURY 3 0.0002
253 CARDIOGENIC SHOCK 3 0.0002
254 GASTROENTERITIS 3 0.0002
255 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
256 ACUTE KIDNEY INJURY 31 0.0002
257 STAPHYLOCOCCAL SEPSIS 1 0.0002
258 DYSPNOEA 114 0.0002
259 HYPERNATRAEMIA 1 0.0002
260 DERMATITIS EXFOLIATIVE 1 0.0002
261 CORONARY ARTERY STENOSIS 1 0.0002
262 DRUG LEVEL DECREASED 2 0.0002
263 INCREASED UPPER AIRWAY SECRETION 1 0.0002
264 CEREBRAL ISCHAEMIA 1 0.0002
265 SKIN NECROSIS 1 0.0002
266 PRODUCT USE ISSUE 36 0.0002
267 PRODUCT ODOUR ABNORMAL 2 0.0002
268 EATING DISORDER 4 0.0002
269 INTERSTITIAL LUNG DISEASE 9 0.0002
270 STRESS FRACTURE 1 0.0002
271 LIMB INJURY 5 0.0002
272 VENTRICULAR TACHYCARDIA 3 0.0002
273 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
274 MACULAR OEDEMA 1 0.0002
275 ACUTE PULMONARY OEDEMA 1 0.0002
276 COLECTOMY 1 0.0002
277 CHOLECYSTITIS ACUTE 1 0.0002
278 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
279 GASTRIC HAEMORRHAGE 2 0.0002
280 LIVER FUNCTION TEST ABNORMAL 5 0.0002
281 NEEDLE ISSUE 5 0.0002
282 SYRINGE ISSUE 3 0.0002
283 CARDIAC DISORDER 16 0.0002
284 ISCHAEMIC STROKE 3 0.0002
285 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
286 OSTEOARTHRITIS 7 0.0002
287 FEELING HOT 10 0.0002
288 ENCEPHALOPATHY 4 0.0002
289 TENDON RUPTURE 2 0.0002
290 NEUTROPENIA 22 0.0002
291 PNEUMONIA ASPIRATION 4 0.0002
292 PROCTALGIA 1 0.0002
293 HAEMOGLOBIN ABNORMAL 1 0.0002
294 CARDIAC FLUTTER 1 0.0002
295 HAEMATOMA 4 0.0002
296 BRADYPHRENIA 1 0.0002
297 POLYP 1 0.0002
298 ORAL CANDIDIASIS 2 0.0002
299 PRODUCT FORMULATION ISSUE 1 0.0002
300 SKIN DISORDER 5 0.0001
301 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
302 POST-TRAUMATIC STRESS DISORDER 1 0.0001
303 JAUNDICE 4 0.0001
304 METASTASES TO LYMPH NODES 1 0.0001
305 COMA 7 0.0001
306 CORONARY ARTERY OCCLUSION 2 0.0001
307 ENCEPHALITIS 1 0.0001
308 AUTOIMMUNE HEPATITIS 1 0.0001
309 FORMICATION 1 0.0001
310 EXTRASYSTOLES 1 0.0001
311 HALLUCINATION, VISUAL 3 0.0001
312 PAPULE 1 0.0001
313 SUBDURAL HAEMATOMA 2 0.0001
314 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
315 PRODUCT SUBSTITUTION ISSUE 8 0.0001
316 HYPOKINESIA 2 0.0001
317 RASH PUSTULAR 1 0.0001
318 SENSITIVE SKIN 1 0.0001
319 DRUG INEFFECTIVE 178 0.0001
320 TRANSAMINASES INCREASED 3 0.0001
321 FEELING DRUNK 1 0.0001
322 ECZEMA 7 0.0001
323 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
324 AORTIC ANEURYSM 1 0.0001
325 HAEMODYNAMIC INSTABILITY 1 0.0001
326 HYPOKALAEMIA 6 0.0001
327 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
328 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
329 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
330 OFF LABEL USE 111 0.0001
331 OCULAR HYPERAEMIA 6 0.0001
332 PANCYTOPENIA 7 0.0001
333 THROMBOCYTOPENIA 14 0.0001
334 BLOOD PRESSURE FLUCTUATION 3 0.0001
335 MIOSIS 1 0.0001
336 DECUBITUS ULCER 1 0.0001
337 EYE DISORDER 4 0.0001
338 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
339 DRUG LEVEL INCREASED 2 0.0001
340 ACUTE CORONARY SYNDROME 1 0.0001
341 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
342 SKIN PLAQUE 1 0.0001
343 FACIAL PARALYSIS 1 0.0001
344 SKIN ULCER 3 0.0001
345 MYOPATHY 1 0.0001
346 HEART RATE DECREASED 4 0.0001
347 LUNG INFILTRATION 1 0.0001
348 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
349 MYOSITIS 1 0.0001
350 CONFUSIONAL STATE 18 0.0001
351 INCREASED TENDENCY TO BRUISE 1 0.0001
352 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
353 DYSURIA 4 0.0001
354 HEPATIC STEATOSIS 2 0.0001
355 ERYTHEMA MULTIFORME 1 0.0001
356 HEPATIC ENCEPHALOPATHY 1 0.0001
357 DIARRHOEA HAEMORRHAGIC 1 0.0001
358 SQUAMOUS CELL CARCINOMA 1 0.0001
359 BLOOD PRESSURE DECREASED 7 0.0001
360 RED BLOOD CELL COUNT DECREASED 3 0.0001
361 HERPES ZOSTER 6 0.0001
362 HYPERCHOLESTEROLAEMIA 1 0.0001
363 SINUS BRADYCARDIA 1 0.0001
364 PARKINSONISM 1 0.0001
365 LUNG DISORDER 5 0.0001
366 HEPATOMEGALY 1 0.0001
367 APHASIA 3 0.0001
368 CORONARY ARTERY DISEASE 3 0.0001
369 DYSKINESIA 4 0.0001
370 HYPERBILIRUBINAEMIA 1 0.0001
371 PETECHIAE 1 0.0001
372 SPEECH DISORDER 5 0.0001
373 FULL BLOOD COUNT ABNORMAL 1 0.0001
374 SUDDEN DEATH 1 0.0001
375 RENAL FAILURE ACUTE 4 0.0001
376 PALPITATIONS 11 0.0001
377 SKIN CANCER 2 0.0001
378 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
379 SKIN LACERATION 1 0.0001
380 SEPTIC SHOCK 4 0.0001
381 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
382 RASH MACULO-PAPULAR 2 0.0001
383 NEPHROPATHY TOXIC 1 0.0001
384 HEART RATE IRREGULAR 2 0.0001
385 IMPAIRED DRIVING ABILITY 1 0.0001
386 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
387 MICTURITION URGENCY 1 0.0001
388 MYOCARDITIS 1 0.0001
389 ELECTROLYTE IMBALANCE 1 0.0001
390 VASCULITIS 1 0.0001
391 SPLENOMEGALY 1 0.0001
392 SPINAL PAIN 1 0.0001
393 BLOOD PRESSURE INCREASED 13 0.0001
394 PRODUCT PRESCRIBING ERROR 2 0.0001
395 MYOCLONUS 1 0.0001
396 PRODUCTIVE COUGH 4 0.0001
397 ACCIDENT 1 0.0001
398 MACULAR DEGENERATION 1 0.0001
399 RENAL FAILURE 11 0.0001
400 HYPOGLYCAEMIA 4 0.0001
401 MYALGIA 14 0.0001
402 PRESYNCOPE 2 0.0001
403 VERTIGO 5 0.0001
404 RESPIRATORY DEPRESSION 1 0.0001
405 OSTEONECROSIS OF JAW 2 0.0001
406 GENERALISED OEDEMA 1 0.0001
407 PEMPHIGUS 1 0.0001
408 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
409 ABDOMINAL PAIN LOWER 2 0.0001
410 INTENTIONAL OVERDOSE 5 0.0001
411 UNRESPONSIVE TO STIMULI 2 0.0001
412 PLATELET COUNT INCREASED 1 0.0001
413 BLOOD CREATININE INCREASED 5 0.0001
414 PULMONARY CONGESTION 1 0.0001
415 EYE HAEMORRHAGE 1 0.0001
416 DISTURBANCE IN ATTENTION 4 0.0001
417 DRUG TOXICITY 1 0.0001
418 PERIPHERAL COLDNESS 1 0.0001
419 POLLAKIURIA 3 0.0001
420 COORDINATION ABNORMAL 1 0.0001
421 WOUND 2 0.0001
422 MASS 1 0.0001
423 CARPAL TUNNEL SYNDROME 1 0.0001
424 SINUS TACHYCARDIA 1 0.0001
425 ANGINA PECTORIS 2 0.0001
426 MYELODYSPLASTIC SYNDROME 1 0.0001
427 APATHY 1 0.0001
428 URINARY INCONTINENCE 2 0.0001
429 ASTHENIA 25 0.0001
430 HALLUCINATION 5 0.0001
431 DEVICE RELATED INFECTION 1 0.0001
432 LIMB DISCOMFORT 2 0.0001
433 EJECTION FRACTION DECREASED 1 0.0001
434 BASAL CELL CARCINOMA 1 0.0001
435 ARRHYTHMIA 3 0.0001
436 ERYTHEMA 13 0.0001
437 HEAD INJURY 2 0.0001
438 PULMONARY EMBOLISM 6 0.0001
439 RESPIRATORY TRACT CONGESTION 1 0.0001
440 OBESITY 1 0.0001
441 ABSCESS 1 0.0001
442 MOVEMENT DISORDER 2 0.0001
443 THROMBOSIS 5 0.0001
444 BLOOD POTASSIUM INCREASED 1 0.0001
445 STAPHYLOCOCCAL INFECTION 2 0.0001
446 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
447 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
448 PERICARDITIS 1 0.0001
449 HEMIPARESIS 1 0.0001
450 CIRCULATORY COLLAPSE 1 0.0001
451 INFLAMMATION 3 0.0001
452 MUSCULOSKELETAL DISCOMFORT 1 0.0001
453 DELIRIUM 2 0.0001
454 MUSCULOSKELETAL PAIN 3 0.0001
455 RASH MACULAR 2 0.0001
456 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
457 GALLBLADDER DISORDER 1 0.0001
458 SOMNOLENCE 11 0.0001
459 EYE SWELLING 2 0.0001
460 BACTERIAL INFECTION 1 0.0001
461 EPISTAXIS 4 0.0001
462 BLISTER 3 0.0001
463 DYSARTHRIA 2 0.0001
464 DYSPNOEA EXERTIONAL 2 0.0001
465 COLITIS 2 0.0001
466 GASTRIC ULCER 1 0.0001
467 CONVULSION 3 0.0001
468 GAIT DISTURBANCE 10 0.0001
469 PULMONARY FIBROSIS 1 0.0001
470 PRESCRIBED OVERDOSE 1 0.0001
471 DYSTONIA 1 0.0001
472 ATRIAL FIBRILLATION 5 0.0001
473 CHOKING 1 0.0001
474 SINUS DISORDER 1 0.0001
475 DISORIENTATION 2 0.0001
476 CYTOKINE RELEASE SYNDROME 1 0.0000
477 PRODUCT ADMINISTRATION ERROR 1 0.0000
478 SUICIDE ATTEMPT 3 0.0000
479 DISCOMFORT 3 0.0000
480 BODY TEMPERATURE INCREASED 1 0.0000
481 NASOPHARYNGITIS 9 0.0000
482 SINUSITIS 5 0.0000
483 VISUAL IMPAIRMENT 6 0.0000
484 PERITONITIS 1 0.0000
485 ABDOMINAL DISTENSION 5 0.0000
486 DERMATITIS 1 0.0000
487 MOUTH ULCERATION 1 0.0000
488 ANAEMIA 9 0.0000
489 HYPERHIDROSIS 6 0.0000
490 POOR QUALITY SLEEP 1 0.0000
491 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
492 ANGIOEDEMA 2 0.0000
493 STEVENS-JOHNSON SYNDROME 1 0.0000
494 TOOTH DISORDER 1 0.0000
495 GASTROINTESTINAL DISORDER 4 0.0000
496 RASH PAPULAR 1 0.0000
497 ADVERSE DRUG REACTION 4 0.0000
498 PANCREATITIS ACUTE 1 0.0000
499 CHROMATURIA 1 0.0000
500 NEPHROLITHIASIS 2 0.0000
501 OROPHARYNGEAL PAIN 4 0.0000
502 CHEST PAIN 8 0.0000
503 WEIGHT DECREASED 12 0.0000
504 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
505 CONDITION AGGRAVATED 13 0.0000
506 ANXIETY 12 0.0000
507 RASH ERYTHEMATOUS 2 0.0000
508 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
509 DIABETIC KETOACIDOSIS 1 0.0000
510 MENTAL IMPAIRMENT 1 0.0000
511 FIBROMYALGIA 1 0.0000
512 PYREXIA 14 0.0000
513 INJECTION SITE ERYTHEMA 5 0.0000
514 MYOCARDIAL INFARCTION 7 0.0000
515 FLUID RETENTION 2 0.0000
516 COUGH 11 0.0000
517 HEPATITIS 1 0.0000
518 DECREASED APPETITE 9 0.0000
519 RASH GENERALISED 1 0.0000
520 ARTHRALGIA 16 0.0000
521 DIZZINESS 19 0.0000
522 HYPERSENSITIVITY 7 0.0000
523 FREQUENT BOWEL MOVEMENTS 1 0.0000
524 OEDEMA 2 0.0000
525 PALLOR 1 0.0000
526 MALAISE 16 0.0000
527 RESPIRATORY DISTRESS 1 0.0000
528 INFLUENZA 4 0.0000
529 HAEMOPTYSIS 1 0.0000
530 NECK PAIN 2 0.0000
531 OXYGEN SATURATION DECREASED 2 0.0000
532 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
533 MUSCULAR WEAKNESS 4 0.0000
534 URINARY TRACT INFECTION 6 0.0000
535 BONE PAIN 2 0.0000
536 ACUTE MYOCARDIAL INFARCTION 1 0.0000
537 INSOMNIA 9 0.0000
538 TACHYCARDIA 3 0.0000
539 WHEEZING 2 0.0000
540 OESOPHAGEAL CARCINOMA 1 0.0000
541 IRRITABILITY 2 0.0000
542 PLEURAL EFFUSION 2 0.0000
543 EPILEPSY 1 0.0000
544 HOSPITALISATION 5 0.0000
545 NERVOUS SYSTEM DISORDER 1 0.0000
546 SWOLLEN TONGUE 1 0.0000
547 METABOLIC ACIDOSIS 1 0.0000
548 PRURITUS 12 0.0000
549 NIGHT SWEATS 1 0.0000
550 SWELLING FACE 2 0.0000
551 FEBRILE NEUTROPENIA 2 0.0000
552 EXPIRED PRODUCT ADMINISTERED 1 0.0000
553 LIP SWELLING 1 0.0000
554 DEHYDRATION 4 0.0000
555 URINARY RETENTION 1 0.0000
556 GAIT INABILITY 1 0.0000
557 URTICARIA 5 0.0000
558 CHEST DISCOMFORT 3 0.0000
559 HAEMATURIA 1 0.0000
560 ILLNESS 3 0.0000
561 HYPOXIA 1 0.0000
562 LYMPHADENOPATHY 1 0.0000
563 CEREBRAL HAEMORRHAGE 1 0.0000
564 MUSCLE SPASMS 5 0.0000
565 INJECTION SITE MASS 1 0.0000
566 HYPOAESTHESIA 4 0.0000
567 HOT FLUSH 2 0.0000
568 ABDOMINAL PAIN 6 0.0000
569 CARDIAC FAILURE 2 0.0000
570 DRY MOUTH 2 0.0000
571 NEUTROPHIL COUNT DECREASED 1 0.0000
572 INFLUENZA LIKE ILLNESS 2 0.0000
573 CARDIAC ARREST 2 0.0000
574 RHABDOMYOLYSIS 1 0.0000
575 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
576 WITHDRAWAL SYNDROME 1 0.0000
577 LOSS OF CONSCIOUSNESS 3 0.0000
578 DIARRHOEA 15 0.0000
579 COVID-19 4 0.0000
580 LIVER DISORDER 1 0.0000
581 COLITIS ULCERATIVE 1 0.0000
582 WEIGHT INCREASED 5 0.0000
583 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
584 MEMORY IMPAIRMENT 3 0.0000
585 TINNITUS 1 0.0000
586 SKIN DISCOLOURATION 1 0.0000
587 RENAL DISORDER 1 0.0000
588 SWELLING 2 0.0000
589 DYSPEPSIA 2 0.0000
590 SYNCOPE 2 0.0000
591 AGGRESSION 1 0.0000
592 CELLULITIS 1 0.0000
593 HAEMOGLOBIN DECREASED 2 0.0000
594 FATIGUE 15 0.0000
595 PARAESTHESIA 3 0.0000
596 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
597 RASH PRURITIC 1 0.0000
598 ANAPHYLACTIC REACTION 1 0.0000
599 TREMOR 3 0.0000
600 ARTHROPATHY 1 0.0000
601 SEPSIS 2 0.0000
602 CEREBROVASCULAR ACCIDENT 3 0.0000
603 NAUSEA 14 0.0000
604 FLATULENCE 1 0.0000
605 LETHARGY 1 0.0000
606 EYE IRRITATION 1 0.0000
607 DYSPHONIA 1 0.0000
608 CHILLS 2 0.0000
609 FEELING ABNORMAL 4 0.0000
610 THERAPEUTIC RESPONSE DECREASED 1 0.0000
611 STOMATITIS 1 0.0000
612 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
613 RASH 7 0.0000
614 PNEUMONIA 5 0.0000
615 DEEP VEIN THROMBOSIS 1 0.0000
616 NEOPLASM MALIGNANT 1 0.0000
617 PRODUCT QUALITY ISSUE 2 0.0000
618 ABDOMINAL PAIN UPPER 3 0.0000
619 HEADACHE 9 0.0000
620 INJURY 1 0.0000
621 SLEEP DISORDER 1 0.0000
622 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
623 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
624 THERAPY INTERRUPTED 1 0.0000
625 RESPIRATORY FAILURE 1 0.0000
626 UNDERDOSE 1 0.0000
627 AGITATION 1 0.0000
628 PAIN IN EXTREMITY 4 0.0000
629 DYSGEUSIA 1 0.0000
630 ACNE 1 0.0000
631 DIABETES MELLITUS 1 0.0000
632 INJECTION SITE SWELLING 1 0.0000
633 BACK PAIN 3 0.0000
634 VOMITING 6 0.0000
635 MUSCULOSKELETAL STIFFNESS 1 0.0000
636 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
637 SUICIDAL IDEATION 1 0.0000
638 BREAST CANCER 1 0.0000
639 DYSPHAGIA 1 0.0000
640 NEUROPATHY PERIPHERAL 1 0.0000
641 ALOPECIA 2 0.0000
642 INJECTION SITE PAIN 3 0.0000
643 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
644 HAEMORRHAGE 1 0.0000
645 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
646 RHEUMATOID ARTHRITIS 1 0.0000
647 INCORRECT DOSE ADMINISTERED 2 0.0000
648 DISEASE PROGRESSION 1 0.0000
649 EMOTIONAL DISTRESS 1 0.0000
650 VISION BLURRED 1 0.0000
651 INFECTION 1 0.0000
652 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
653 DEATH 2 0.0000